Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0000899243-22-001618

Director bought 645,000 shares at an average $1.00 ($642,931)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ARMISTICE CAPITAL, LLC Director 2022-01-07 Purchase +137,900 $1.04 $142,975 45,137,900 I: show line 1 in the form
ARMISTICE CAPITAL, LLC Director 2022-01-10 Purchase +491,097 $0.99 $484,615 45,628,997 I: show line 2 in the form
ARMISTICE CAPITAL, LLC Director 2022-01-11 Purchase +16,003 $0.96 $15,342 45,645,000 I: show line 3 in the form
Open-market purchases · 645,000 sh · avg $1.00 · $642,931
Loading xslF345X03/doc4.xml…